What tests should I get after a Desmoid Tumors diagnosis

Tests After a Desmoid Tumor Diagnosis

After being diagnosed with a desmoid tumor (also called aggressive fibromatosis), there are several important tests and evaluations you should have. Let me walk you through what the medical guidelines recommend.

Initial Workup Tests

According to NCCN Guidelines for Soft Tissue Sarcoma, your care team should perform:

1. History and Physical Examination (H&P)

Your doctor will take a detailed medical history and perform a thorough physical exam. This is important because desmoid tumors can be associated with Gardner syndrome (also called familial adenomatous polyposis or FAP) — a genetic condition that increases desmoid tumor risk. Your doctor will specifically ask about:

• Family history of colon cancer or polyps
• Any personal history of colon problems
• Symptoms related to your tumor

2. Imaging of the Primary Tumor Site

You'll need imaging to see the tumor clearly. Your doctor will choose either:

• MRI (magnetic resonance imaging) — often preferred because it shows soft tissue detail very well
• CT (computed tomography) — another good option depending on tumor location

The imaging helps your care team understand:

• Exact size and location of the tumor
• Whether it's invading nearby structures
• How it relates to important nerves and blood vessels

3. Biopsy (if needed)

A biopsy means taking a small tissue sample to confirm the diagnosis under a microscope. According to NCCN Guidelines, a biopsy should be performed for suspicious masses to confirm desmoid tumor diagnosis. However, biopsy may not be necessary if you're planning complete surgical removal anyway.

Genetic Testing to Consider

CTNNB1 Gene Mutation Testing

This is an important test that looks for mutations in the CTNNB1 gene (which controls a protein called beta-catenin). Here's why this matters:

What the research shows:

• About 85-87% of desmoid tumors have CTNNB1 mutations
• Certain mutations (like the 45F mutation) are associated with higher recurrence risk — meaning the tumor is more likely to come back after surgery
• Patients with ANY CTNNB1 mutation have worse 5-year recurrence-free survival (49%) compared to those without mutations (75%)

However, the NCCN Guidelines note that the clinical usefulness of CTNNB1 testing is still being studied. Some research shows it helps predict recurrence risk, while other studies haven't found clear differences. Your doctor may recommend this test to help guide treatment decisions, but it's not yet standard for all patients.

Evaluation for FAP/Gardner Syndrome

If you have a desmoid tumor, your doctor should evaluate you for familial adenomatous polyposis (FAP) because:

• 7.5-16% of FAP patients develop desmoid tumors
• If you have FAP, this changes your management and screening needs
• Your family members may need screening too

This evaluation typically includes:

• Detailed family history
• Possible referral to a genetic counselor
• Possible colonoscopy screening (if not already done)
• Genetic testing if FAP is suspected

Multidisciplinary Team Evaluation

NCCN Guidelines emphasize that all patients should be managed by a multidisciplinary team with expertise in desmoid tumors. This team typically includes:

• Surgical oncologist (cancer surgeon)
• Medical oncologist (chemotherapy specialist)
• Radiation oncologist (radiation therapy specialist)
• Radiologist (imaging specialist)
• Pathologist (tissue specialist)

Important Questions to Ask Your Care Team

1. Do I need CTNNB1 genetic testing, and if so, what will it tell us about my specific case?

2. Should I be evaluated for Gardner syndrome/FAP? (especially important if you have family history of colon cancer or polyps)

3. What imaging will you use to monitor my tumor, and how often will I need scans? (NCCN Guidelines recommend initial imaging every 3 months, though frequency depends on your specific situation)

4. Based on my tumor's location and size, what are my treatment options? (This depends heavily on whether your tumor is in the abdomen, extremity, or other location)

5. Will you recommend any additional molecular testing beyond standard pathology?

Key Point About Your Situation

Desmoid tumors are unique because they rarely spread to distant sites (metastasize), but they do have a high tendency to recur locally after surgery. This is why careful imaging follow-up and sometimes additional testing is important — your care team is watching for local recurrence, not distant spread.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Soft Tissue Sarcoma (Version 1.2025) — Desmoid Tumors section